Cargando…

To pool or not to pool: Can we ignore cross-trial variability in FMRI?

In this work, we investigate the importance of explicitly accounting for cross-trial variability in neuroimaging data analysis. To attempt to obtain reliable estimates in a task-based experiment, each condition is usually repeated across many trials. The investigator may be interested in (a) conditi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Gang, Padmala, Srikanth, Chen, Yi, Taylor, Paul A., Cox, Robert W., Pessoa, Luiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861143/
https://www.ncbi.nlm.nih.gov/pubmed/33181352
http://dx.doi.org/10.1016/j.neuroimage.2020.117496
_version_ 1783647022864138240
author Chen, Gang
Padmala, Srikanth
Chen, Yi
Taylor, Paul A.
Cox, Robert W.
Pessoa, Luiz
author_facet Chen, Gang
Padmala, Srikanth
Chen, Yi
Taylor, Paul A.
Cox, Robert W.
Pessoa, Luiz
author_sort Chen, Gang
collection PubMed
description In this work, we investigate the importance of explicitly accounting for cross-trial variability in neuroimaging data analysis. To attempt to obtain reliable estimates in a task-based experiment, each condition is usually repeated across many trials. The investigator may be interested in (a) condition-level effects, (b) trial-level effects, or (c) the association of trial-level effects with the corresponding behavior data. The typical strategy for condition-level modeling is to create one regressor per condition at the subject level with the underlying assumption that responses do not change across trials. In this methodology of complete pooling, all cross-trial variability is ignored and dismissed as random noise that is swept under the rug of model residuals. Unfortunately, this framework invalidates the generalizability from the confine of specific trials (e.g., particular faces) to the associated stimulus category (“face”), and may inflate the statistical evidence when the trial sample size is not large enough. Here we propose an adaptive and computationally tractable framework that meshes well with the current two-level pipeline and explicitly accounts for trial-by-trial variability. The trial-level effects are first estimated per subject through no pooling. To allow generalizing beyond the particular stimulus set employed, the cross-trial variability is modeled at the population level through partial pooling in a multilevel model, which permits accurate effect estimation and characterization. Alternatively, trial-level estimates can be used to investigate, for example, brain-behavior associations or correlations between brain regions. Furthermore, our approach allows appropriate accounting for serial correlation, handling outliers, adapting to data skew, and capturing nonlinear brain-behavior relationships. By applying a Bayesian multilevel model framework at the level of regions of interest to an experimental dataset, we show how multiple testing can be addressed and full results reported without arbitrary dichotomization. Our approach revealed important differences compared to the conventional method at the condition level, including how the latter can distort effect magnitude and precision. Notably, in some cases our approach led to increased statistical sensitivity. In summary, our proposed framework provides an effective strategy to capture trial-by-trial responses that should be of interest to a wide community of experimentalists.
format Online
Article
Text
id pubmed-7861143
institution National Center for Biotechnology Information
language English
publishDate 2020
record_format MEDLINE/PubMed
spelling pubmed-78611432021-02-04 To pool or not to pool: Can we ignore cross-trial variability in FMRI? Chen, Gang Padmala, Srikanth Chen, Yi Taylor, Paul A. Cox, Robert W. Pessoa, Luiz Neuroimage Article In this work, we investigate the importance of explicitly accounting for cross-trial variability in neuroimaging data analysis. To attempt to obtain reliable estimates in a task-based experiment, each condition is usually repeated across many trials. The investigator may be interested in (a) condition-level effects, (b) trial-level effects, or (c) the association of trial-level effects with the corresponding behavior data. The typical strategy for condition-level modeling is to create one regressor per condition at the subject level with the underlying assumption that responses do not change across trials. In this methodology of complete pooling, all cross-trial variability is ignored and dismissed as random noise that is swept under the rug of model residuals. Unfortunately, this framework invalidates the generalizability from the confine of specific trials (e.g., particular faces) to the associated stimulus category (“face”), and may inflate the statistical evidence when the trial sample size is not large enough. Here we propose an adaptive and computationally tractable framework that meshes well with the current two-level pipeline and explicitly accounts for trial-by-trial variability. The trial-level effects are first estimated per subject through no pooling. To allow generalizing beyond the particular stimulus set employed, the cross-trial variability is modeled at the population level through partial pooling in a multilevel model, which permits accurate effect estimation and characterization. Alternatively, trial-level estimates can be used to investigate, for example, brain-behavior associations or correlations between brain regions. Furthermore, our approach allows appropriate accounting for serial correlation, handling outliers, adapting to data skew, and capturing nonlinear brain-behavior relationships. By applying a Bayesian multilevel model framework at the level of regions of interest to an experimental dataset, we show how multiple testing can be addressed and full results reported without arbitrary dichotomization. Our approach revealed important differences compared to the conventional method at the condition level, including how the latter can distort effect magnitude and precision. Notably, in some cases our approach led to increased statistical sensitivity. In summary, our proposed framework provides an effective strategy to capture trial-by-trial responses that should be of interest to a wide community of experimentalists. 2020-10-24 2021-01-15 /pmc/articles/PMC7861143/ /pubmed/33181352 http://dx.doi.org/10.1016/j.neuroimage.2020.117496 Text en This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Article
Chen, Gang
Padmala, Srikanth
Chen, Yi
Taylor, Paul A.
Cox, Robert W.
Pessoa, Luiz
To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title_full To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title_fullStr To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title_full_unstemmed To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title_short To pool or not to pool: Can we ignore cross-trial variability in FMRI?
title_sort to pool or not to pool: can we ignore cross-trial variability in fmri?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861143/
https://www.ncbi.nlm.nih.gov/pubmed/33181352
http://dx.doi.org/10.1016/j.neuroimage.2020.117496
work_keys_str_mv AT chengang topoolornottopoolcanweignorecrosstrialvariabilityinfmri
AT padmalasrikanth topoolornottopoolcanweignorecrosstrialvariabilityinfmri
AT chenyi topoolornottopoolcanweignorecrosstrialvariabilityinfmri
AT taylorpaula topoolornottopoolcanweignorecrosstrialvariabilityinfmri
AT coxrobertw topoolornottopoolcanweignorecrosstrialvariabilityinfmri
AT pessoaluiz topoolornottopoolcanweignorecrosstrialvariabilityinfmri